Key Pharmacokinetic Differences# The critical difference lies in their albumin binding and metabolic stability: Semaglutide's longer half-life results from three structural modifications: an aminoisobutyric acid (Aib) substitution at position 2 that confers DPP-4 resistance, a C18 fatty diacid (vs C16 in liraglutide) that strengthens albumin binding, and a hydrophilic linker that optimizes the fatty acid orientation
Beyond their protective roles, these components also participate in vascular inflammation, thrombosis, and autoimmunity, underscoring their dual biological impact
Unlike brand-name medications with extensive stability testing, compounded formulations have shorter beyond-use dates, typically 30 to 90 days
Product Specifications Store at room temperature
The board was able to take quick action after an inspector using the National Association of Boards of Pharmacy (NABP)s product verification technology, Pulse, rapidly confirmed that the product was counterfeit